Function-based Enrichment of Pro-angiogenic Cells for Cardiac Repair

基于功能的促血管生成细胞富集用于心脏修复

• 批准号: G0900912/1
• 负责人: Paolo Madeddu
• 金额: $ 38.17万
• 依托单位: University of Bristol
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2010
• 资助国家: 英国
• 起止时间: 2010 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=G0900912%2F1
• 关键词: Function; based; Enrichment; Pro; angiogenic

Heart disease is the most common course for death and illness across Europe. Standard therapy can rescue and preserve heart function only to a certain degree, still leaving the patient with a poor quality of life. Initial studies have tested the potential of injecting the patient s own bone marrow stem cells into the damaged heart muscle. We therefore know that the treatment is safe and can improve heart function more than classical therapy alone. However, researchers believe that the cells which are injected should be characterised and selected better to make sure they perform their supposed function.In the proposed study, we want to select for cells which are able to actively travel towards a substance involved in attraction of regenerative stem cells. We have demonstrated before that this method can be used to isolate cells which have certain characteristics necessary for their beneficial action. However, the better function of the selected cells needs to be demonstrated in a mouse model mirroring the situation of the human patient. Once we have shown that cells selected on the basis of their functional ability perform better than currently used cells, we will be in the position to develop a clinically applicable method improving the efficiency of stem cell therapy.

心脏病是欧洲最常见的死亡和疾病。标准治疗只能在一定程度上挽救和保护心脏功能，但仍然使患者的生活质量很差。最初的研究已经测试了将患者自己的骨髓干细胞注射到受损心肌中的潜力。因此，我们知道该治疗是安全的，并且比单独的经典治疗更能改善心脏功能。然而，研究人员认为，注射的细胞应该被更好地表征和选择，以确保它们发挥其应有的功能。在拟议的研究中，我们希望选择能够积极前往参与吸引再生干细胞的物质的细胞。我们以前已经证明，这种方法可以用于分离具有有益作用所必需的某些特征的细胞。然而，需要在反映人类患者情况的小鼠模型中证明所选细胞的更好功能。一旦我们证明基于其功能能力选择的细胞比目前使用的细胞表现更好，我们将能够开发出一种临床适用的方法，提高干细胞治疗的效率。